Investigational Site Number : 2500003

Paris, Washington 75013

1 studies enrolling now · 1 studies all time

What they study most

Plasma Cell Myeloma Refractory

Studies at this site

• Isatuximab in Combination With Novel Agents in RRMM - Master Protocol — Recruiting now